Embryonic Stem Cells and Released Factors Stimulate c-kit+/FLK-1+ Progenitor Cells and Promote Neovascularization in Doxorubicin-Induced Cardiomyopathy

Cell Transplantation

Volumn 24, Issue 6, 2015, Pages 1043-1052

  Singla, Dinender K ^a   Abdelli, Latifa S ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Doxorubicin; Embryonic stem cells; Neovascularization

Indexed keywords

CD31 ANTIGEN; CONDITIONED MEDIUM; DOXORUBICIN; STEM CELL FACTOR RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL; APOPTOSIS; BLOOD VESSEL; C57BL MOUSE; CARDIAC MUSCLE; CARDIOMYOPATHY; CHEMICALLY INDUCED; CHRONIC DISEASE; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; FEMALE; GROWTH, DEVELOPMENT AND AGING; HEART FUNCTION TEST; MALE; METABOLISM; MOUSE; MOUSE EMBRYONIC STEM CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHARMACOLOGY; STEM CELL TRANSPLANTATION;

ANIMALS; ANTIGENS, CD31; APOPTOSIS; BLOOD VESSELS; CARDIOMYOPATHIES; CHRONIC DISEASE; CULTURE MEDIA, CONDITIONED; DOXORUBICIN; FEMALE; HEART FUNCTION TESTS; MALE; MICE; MICE, INBRED C57BL; MOUSE EMBRYONIC STEM CELLS; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84991218839     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368914X679219     Document Type: Article

References (35)

1. Agbulut, O.; Menot, M. L.; Li, Z.; Marotte, F.; Paulin, D.; Hagege, A. A.; Chomienne, C.; Samuel, J. L.; Menasche, P. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc. Res. 58:451–459; 2003.
2. Dentelli, P.; Rosso, A.; Balsamo, A.; Colmenares, B. S.; Zeoli, A.; Pegoraro, M.; Camussi, G.; Pegoraro, L.; Brizzi, M. F. C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 109:4264–4271; 2007.
3. Fatma, S.; Selby, D. E.; Singla, R. D.; Singla, D. K. Factors released from embryonic stem cells stimulate c-kit-FLK-1(+ve) progenitor cells and enhance neovascularization. Antioxid. Redox Signal. 13:1857–1865; 2010.
4. Fazel, S. S.; Chen, L.; Angoulvant, D.; Li, S. H.; Weisel, R. D.; Keating, A.; Li, R. K. Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury. FASEB J. 22:930–940; 2008.
5. Garbade, J.; Dhein, S.; Lipinski, C.; Aupperle, H.; Arsalan, M.; Borger, M. A.; Barten, M. J.; Lehmann, S.; Walther, T.; Mohr, F. W. Bone marrow-derived stem cells attenuate impaired contractility and enhance capillary density in a rabbit model of doxorubicin-induced failing hearts. J. Card. Surg. 24:591–599; 2009.
6. Geisberg, C. A.; Sawyer, D. B. Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage. Curr. Hypertens. Rep. 12:404–410; 2010.
7. Glass, C.; Singla, D. K. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart. Am. J. Physiol. Heart Circ. Physiol. 301: H2038–H2049; 2011.
8. Glass, C.; Singla, D. K. Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction. Cell Transplant. 21:1931– 1944; 2012.
9. Haider, H. K.; Ashraf, M. Bone marrow cell transplantation in clinical perspective. J. Mol. Cell. Cardiol. 38:225–235; 2005.
10. Haider, H. K.; Ashraf, M. Bone marrow stem cell transplantation for cardiac repair. Am. J. Physiol. Heart Circ. Physiol. 288:H2557–H2567; 2005.
11. Horenstein, M. S.; Vander Heide, R. S.; L’Ecuyer, T. J. Molecular basis of anthracycline-induced cardiotoxicity and its prevention. Mol. Genet. Metab. 71:436–444; 2000.
12. Kelly, D. J.; Zhang, Y.; Gow, R. M.; Itescu, S.; Gilbert, R. E. Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes. Diab. Vasc. Dis. Res. 2: 76–80; 2005.
13. Kumar, D.; Kirshenbaum, L.; Li, T.; Danelisen, I.; Singal, P. Apoptosis in isolated adult cardiomyocytes exposed to adriamycin. Ann. N. Y. Acad. Sci. 874:156–168; 1999.
14. Li, T. S.; Hamano, K.; Nishida, M.; Hayashi, M.; Ito, H.; Mikamo, A.; Matsuzaki, M. CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am. J. Physiol. Heart Circ. Physiol. 285: H931–H937; 2003.
15. Li, T. S.; Mikamo, A.; Takahashi, M.; Suzuki, R.; Ueda, K.; Ikeda, Y.; Matsuzaki, M.; Hamano, K. Comparison of cell therapy and cytokine therapy for functional repair in ischemic and nonischemic heart failure. Cell Transplant. 16: 365–374; 2007.
16. Li, T. S.; Takahashi, M.; Ohshima, M.; Qin, S. L.; Kubo, M.; Muramatsu, K.; Hamano, K. Myocardial repair achieved by the intramyocardial implantation of adult cardiomyocytes in combination with bone marrow cells. Cell Transplant. 17: 695–703; 2008.
17. Mallat, Z.; Tedgui, A. Apoptosis in the vasculature: Mechanisms and functional importance. Br. J. Pharmacol. 130: 947–962; 2000.
18. Menasche, P. Cellular transplantation: Hurdles remaining before widespread clinical use. Curr. Opin. Cardiol. 19: 154–161; 2004.
19. Menasche, P. Myoblast-based cell transplantation. Heart Fail. Rev. 8:221–227; 2003.
20. Minotti, G.; Menna, P.; Salvatorelli, E.; Cairo, G.; Gianni, L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56:185–229; 2004.
21. Orlic, D.; Kajstura, J.; Chimenti, S.; Bodine, D. M.; Leri, A.; Anversa, P. Bone marrow stem cells regenerate infarcted myocardium. Pediatr. Transplant. 7(Suppl 3):86–88; 2003.
22. Orlic, D.; Kajstura, J.; Chimenti, S.; Limana, F.; Jakoniuk, I.; Quaini, F.; Nadal-Ginard, B.; Bodine, D. M.; Leri, A.; Anversa, P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98:10344–10349; 2001.
23. Psaltis, P. J.; Carbone, A.; Leong, D. P.; Lau, D. H.; Nelson, A. J.; Kuchel, T.; Jantzen, T.; Manavis, J.; Williams, K.; Sanders, P.; Gronthos, S.; Zannettino, A. C.; Worthley, S. G. Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy. Int. J. Cardiovasc. Imaging 27:25–37; 2011.
24. Singal, P. K.; Iliskovic, N.; Li, T.; Kumar, D. Adriamycin cardiomyopathy: Pathophysiology and prevention. FASEB J. 11:931–936; 1997.
25. Singla, D. K. Embryonic stem cells in cardiac repair and regeneration. Antioxid. Redox Signal. 11:1857–1863; 2009.
26. Singla, D. K.; Ahmed, A.; Singla, R.; Yan, B. Embryonic stem cells improve cardiac function in doxorubicin-induced cardiomyopathy mediated through multiple mechanisms. Cell Transplant. 21:1919–1930; 2012.
27. Singla, D. K.; McDonald, D. E. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am. J. Physiol. Heart Circ. Physiol. 293:H1590–H1595; 2007.
28. Singla, D. K.; Singla, R. D.; McDonald, D. E. Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway. Am. J. Physiol. Heart Circ. Physiol. 295:H907–H913; 2008.
29. Singla, D. K.; Singla, R. D.; Lamm, S.; Glass, C. TGF-beta2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium. Am. J. Physiol. Heart Circ. Physiol. 300: H1442–H1450; 2011.
30. Singla, D. K.; Lyons, G. E.; Kamp, T. J. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am. J. Physiol. Heart Circ. Physiol. 293:H1308–H1314; 2007.
31. Vilquin, J. T.; Marolleau, J. P.; Hagege, A.; Menasche, P.; Fiszman, M.; Schwartz, K. Cell transplantation for postischemic heart failure. Arch. Mal. Coeur Vaiss. 95:1219– 1225; 2002.
32. Xiong, Q.; Hill, K. L.; Li, Q.; Suntharalingam, P.; Mansoor, A.; Wang, X.; Jameel, M. N.; Zhang, P.; Swingen, C.; Kaufman, D. S.; Zhang, J. A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells 29:367–375; 2011.
33. Yamahara, K.; Itoh, H. Potential use of endothelial progenitor cells for regeneration of the vasculature. Ther. Adv. Cardiovasc. Dis. 3:17–27; 2009.
34. Zhao, Y.; McLaughlin, D.; Robinson, E.; Harvey, A. P.; Hookham, M. B.; Shah, A. M.; McDermott, B. J.; Grieve, D. J. Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with doxorubicin chemotherapy. Cancer Res. 70:9287–9297; 2010.
35. Zhou, Y. L.; Zhang, H. F.; Li, X. L.; Di, R. M.; Yao, W. M.; Li, D. F.; Feng, J. L.; Huang, J.; Cao, K. J.; Fu, M. Increased stromal-cell-derived factor 1 enhances the homing of bone marrow derived mesenchymal stem cells in dilated cardiomyopathy in rats. Chin. Med. J. 123:3282–3287; 2010.